Krishna Institute of Medical Sciences Limited
NSEI:KIMS Stock Report
Krishna Institute of Medical Sciences Future Growth
Future criteria checks 5/6 Krishna Institute of Medical Sciences is forecast to grow earnings and revenue by 24.7% and 22.2% per annum respectively. EPS is expected to grow by 1.7% per annum. Return on equity is forecast to be 19.3% in 3 years.
Key information
24.7%
Earnings growth rate
Healthcare earnings growth 27.5% Revenue growth rate 22.2% Future return on equity 19.3% Analyst coverage Good
Last updated 12 Nov 2024
Recent future growth updates
Show all updates
Krishna Institute of Medical Sciences Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions Nov 13
Second quarter 2025 earnings released: EPS: ₹2.68 (vs ₹2.30 in 2Q 2024) Nov 10
Krishna Institute of Medical Sciences Limited (NSEI:KIMS) acquired an additional 2.24% stake in KIMS-SUNSHINE Hospitals for approximately INR 400 million. Oct 30
Krishna Institute of Medical Sciences Limited to Report Q2, 2025 Results on Nov 09, 2024 Oct 25
Krishna Institute of Medical Sciences Limited (NSEI:KIMS) acquired an additional 2.21% stake in KIMS-SUNSHINE Hospitals for approximately INR 365.16 million. Oct 22
There's Reason For Concern Over Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Massive 26% Price Jump Sep 05
Krishna Institute of Medical Sciences Limited (NSEI:KIMS) Completed the acquisition of Chalasani Hospitals Private Limited. Aug 31
Price target increased by 7.1% to ₹2,419 Aug 26
We Think The Compensation For Krishna Institute of Medical Sciences Limited's (NSE:KIMS) CEO Looks About Right Aug 23
Krishna Institute of Medical Sciences Limited (NSE:KIMS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year Aug 10
First quarter 2025 earnings: EPS and revenues exceed analyst expectations Aug 08
Krishna Institute of Medical Sciences Limited to Report Q1, 2025 Results on Aug 07, 2024 Jul 25
Krishna Institute of Medical Sciences Limited (NSEI:KIMS) entered into agreement to acquire Chalasani Hospitals Private Limited for INR 750 million. Jul 09
Is Krishna Institute of Medical Sciences (NSE:KIMS) Using Too Much Debt? Jul 02
Krishna Institute of Medical Sciences Limited's (NSE:KIMS) Shares May Have Run Too Fast Too Soon Jun 12
Full year 2024 earnings: EPS and revenues miss analyst expectations May 18
Krishna Institute of Medical Sciences Limited, Annual General Meeting, Aug 29, 2024 May 18
Krishna Institute of Medical Sciences Limited to Report Q4, 2024 Results on May 16, 2024 May 05
Is Now The Time To Put Krishna Institute of Medical Sciences (NSE:KIMS) On Your Watchlist? Apr 28
We Like These Underlying Return On Capital Trends At Krishna Institute of Medical Sciences (NSE:KIMS) Apr 10
Risks To Shareholder Returns Are Elevated At These Prices For Krishna Institute of Medical Sciences Limited (NSE:KIMS) Feb 29
Price target increased by 8.3% to ₹2,327 Feb 27
Krishna Institute of Medical Sciences Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now Feb 08
New minor risk - Financial position Feb 06
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Feb 04
Krishna Institute of Medical Sciences Limited Announces Cessation of Rajeswara Rao Gandu as Independent Director Jan 25
Krishna Institute of Medical Sciences Limited to Report Q3, 2024 Results on Feb 03, 2024 Jan 23
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Shares Could Be 34% Above Their Intrinsic Value Estimate Jan 23
Krishna Institute of Medical Sciences Limited (NSEI:KIMS) acquired 5.04% stake in KIMS-SUNSHINE Hospitals for INR 740 million. Jan 10
Krishna Institute of Medical Sciences Limited Announces Ceasation of Pankaj Vaish as Independent Director Jan 08
Krishna Institute of Medical Sciences Limited Appoints Adwik Bollineni as Additional Director Nov 29
Krishna Institute of Medical Sciences Limited Appoints Adwik Bollineni as Additional Director Nov 28
Investors Will Want Krishna Institute of Medical Sciences' (NSE:KIMS) Growth In ROCE To Persist Nov 21
Krishna Institute of Medical Sciences Limited Announces Resignation of Shantanu Rastogi as Non-Executive & Non-Independent Director Nov 08
Second quarter 2024 earnings: EPS and revenues exceed analyst expectations Nov 08
Krishna Institute of Medical Sciences Limited (NSEI:KIMS) acquired an additional 6.86% in Spanv Medisearch Lifesciences Private Limited Nov 02
Krishna Institute of Medical Sciences Limited to Report Q2, 2024 Results on Nov 07, 2023 Oct 31
Krishna Institute of Medical Sciences Limited (NSEI:KIMS) acquired an additional 5.72% stake in Spanv Medisearch Lifesciences Private Limited for approximately INR 222 million. Oct 27
Price target increased by 8.0% to ₹2,099 Oct 13
Do Krishna Institute of Medical Sciences' (NSE:KIMS) Earnings Warrant Your Attention? Aug 23
Price target increased by 8.6% to ₹1,826 Aug 09
Full year 2023 earnings: EPS exceeds analyst expectations Aug 07
Krishna Institute of Medical Sciences Limited (NSEI:KIMS) acquired an additional 2.49% stake in Sarvejana Healthcare Private Limited for INR 350 million. Aug 04
Krishna Institute of Medical Sciences Limited (NSEI:KIMS) acquired an additional 2.49% stake in Sarvejana Healthcare Private Limited for INR 350 million. Aug 03
Returns Are Gaining Momentum At Krishna Institute of Medical Sciences (NSE:KIMS) Aug 02
Krishna Institute of Medical Sciences Limited to Report Q1, 2024 Results on Aug 07, 2023 Jul 31
Krishna Institute of Medical Sciences Limited Appoints Mr. Sachin Ashok Salvi as the Chief Financial Officer, Effect from August 01, 2023 Jul 27 Krishna Institute of Medical Sciences Limited, Annual General Meeting, Aug 30, 2023
Full year 2023 earnings: EPS exceeds analyst expectations May 19
Krishna Institute of Medical Sciences Limited to Report Q4, 2023 Results on May 18, 2023 May 13
Krishna Institute of Medical Sciences' (NSE:KIMS) Returns On Capital Are Heading Higher Apr 01
Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind Feb 12
Krishna Institute of Medical Sciences Limited to Report Q3, 2023 Results on Feb 09, 2023 Jan 28
Krishna Institute of Medical Sciences Limited (NSEI:KIMS) acquired additional 5.53% stake in Sarvejana Healthcare Private Limited. Jan 08
Krishna Institute of Medical Sciences (NSE:KIMS) Is Looking To Continue Growing Its Returns On Capital Dec 14
Krishna Institute of Medical Sciences Limited Announces Resignation of Mr. Shantanu Rastogi as Director (Non-Executive) Dec 09
Krishna Institute of Medical Sciences Limited (BSE:543308) acquired 4.07% stake in KIMS Hospital Enterprises Private Ltd for INR 245 million. Dec 03
Krishna Institute of Medical Sciences Limited (BSE:543308) acquired additional 7.79% stake in Arunodaya Hospitals Private Limited. Nov 30
Second quarter 2023 earnings: EPS and revenues exceed analyst expectations Nov 16
Second quarter 2023 earnings: EPS and revenues exceed analyst expectations Nov 13
Krishna Institute of Medical Sciences Limited to Report Q2, 2023 Results on Nov 11, 2022 Oct 28
Price target increased to ₹1,509 Oct 04
Krishna Institute of Medical Sciences Limited (BSE:543308) acquired majority stake 51% Spanv Medisearch Lifesciences Private Limited. Sep 13
Krishna Institute of Medical Sciences Limited (BSE:543308) agreed to acquire 51% Spanv Medisearch Lifesciences Private Limited. Aug 30
Analysts Have Made A Financial Statement On Krishna Institute of Medical Sciences Limited's (NSE:KIMS) First-Quarter Report Aug 13
Krishna Institute of Medical Sciences (NSE:KIMS) Is Investing Its Capital With Increasing Efficiency Aug 12
Full year 2022 earnings: EPS in line with expectations, revenues disappoint Jul 20
Here's Why Krishna Institute of Medical Sciences (NSE:KIMS) Has Caught The Eye Of Investors Jul 02
Krishna Institute of Medical Sciences Limited (BSE:543308) agreed to acquire 51% stake in KIMS Manavata Hospital. Jun 15
Full year 2022 earnings: EPS in line with expectations, revenues disappoint May 30 Krishna Institute of Medical Sciences Limited, Annual General Meeting, Aug 11, 2022
Krishna Institute of Medical Sciences Limited (NSE:KIMS) Investors Are Less Pessimistic Than Expected May 08
Insufficient new directors Apr 27
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Feb 13
Krishna Institute of Medical Sciences Limited to Report Q3, 2022 Results on Feb 10, 2022 Feb 09
Insufficient new directors Feb 02
Investor sentiment improved over the past week Aug 17
First quarter 2022 earnings released: EPS ₹11.48 (vs ₹3.85 in 1Q 2021) Aug 12
Investor Director Sandeep Naik has left the company Aug 11
Earnings and Revenue Growth Forecasts NSEI:KIMS - Analysts future estimates and past financials data (INR Millions) Date Revenue Earnings Free Cash Flow Cash from Op Avg. No. Analysts 3/31/2027 47,176 6,287 3,836 9,626 9 3/31/2026 37,985 4,673 2,720 7,564 13 3/31/2025 30,701 3,889 -2,967 6,423 11 9/30/2024 27,053 3,313 -2,409 4,964 N/A 6/30/2024 25,805 3,159 N/A N/A N/A 3/31/2024 24,981 3,101 -1,262 5,211 N/A 12/31/2023 24,403 3,379 N/A N/A N/A 9/30/2023 23,966 3,421 -2,263 4,621 N/A 6/30/2023 23,082 3,472 N/A N/A N/A 3/31/2023 21,977 3,363 -1,424 4,321 N/A 12/31/2022 19,941 3,237 N/A N/A N/A 9/30/2022 18,255 3,289 741 3,693 N/A 6/30/2022 16,732 3,135 N/A N/A N/A 3/31/2022 16,508 3,327 1,537 3,240 N/A 12/31/2021 16,370 3,098 N/A N/A N/A 9/30/2021 16,041 2,774 2,318 3,488 N/A 6/30/2021 16,020 2,792 N/A N/A N/A 3/31/2021 13,299 2,012 2,615 3,560 N/A 12/31/2020 12,412 1,721 3,180 3,774 N/A 3/31/2020 11,227 1,192 1,495 2,015 N/A 3/31/2019 9,204 -477 566 1,339 N/A 3/31/2018 6,652 -474 N/A 1,058 N/A 3/31/2017 5,689 326 N/A 815 N/A 3/31/2016 5,145 266 N/A 955 N/A 3/31/2015 4,222 56 N/A 639 N/A 3/31/2014 3,569 69 N/A 778 N/A
Show more
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KIMS's forecast earnings growth (24.7% per year) is above the savings rate (6.7%).
Earnings vs Market: KIMS's earnings (24.7% per year) are forecast to grow faster than the Indian market (17.9% per year).
High Growth Earnings: KIMS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: KIMS's revenue (22.2% per year) is forecast to grow faster than the Indian market (10.5% per year).
High Growth Revenue: KIMS's revenue (22.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: KIMS's Return on Equity is forecast to be low in 3 years time (19.3%).
Discover growth companies Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
